MicroRNA in Prostate Cancer Racial Disparities and Aggressiveness
Abstract
Activities during this first year of the project were focused on Tasks 1 and 2 of the statement of work, as planned. Task 1 (months 1-30) is to obtain blood and data for 300 new study subjects. Enrollment opened on March 4, 2014. Between March 4 and September 30, 2014, 44 men were enrolled in the study (Task 1.a), for a total of 553 men towards our goal of 800 men. Of these newly enrolled men, blood was collected on 17 (Task 1.b), for a total of 459 blood samples. Three pre-treatment blood samples were collected (Task 1.c), for a total of 86 towards our goal of 150 pre-treatment samples. Questionnaires were completed by 41 men (Task 1.d), for a total of 529 completed questionnaires. Our enrollment rate among eligible men is~95%. Related to Task 2, we have actively followed all of the enrolled men in the cohort (from the previously funded study and from the current protocol) who did not have extensive disease at diagnosis for PSA outcomes. Mean follow-up time is currently 35 months. Follow-up of PSA test results through medical records and Caisis database have just been updated, and a linkage with Metropolitan Detroit SEER registry (MDCSS) for vital status is underway.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2014
- Accession Number
- ADA613715
Entities
People
- Cathryn Bock
Organizations
- Wayne State University